Risk of venous thromboembolism in users of hormone replacement therapy
Authors:
- Martin P VesseyMVMartin P Vessey
- Michael M HawkinsMHMichael M Hawkins
- Jeffrey L CarsonJCJeffrey L Carson
- Parimala GoughPGParimala Gough
- Sally MarshSMSally Marsh
- 1 October 1996
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 348 (9033) , 977-980
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prospective study of exogenous hormones and risk of pulmonary embolism in womenThe Lancet, 1996
- Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogensThe Lancet, 1996
- Women doctors' use of hormone replacement therapyBMJ, 1996
- Hormone replacement therapy in a risk-benefit perspectiveMaturitas, 1996
- Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control studyThe Lancet, 1995
- The epidemiology of coronary heart disease and estrogen replacement in postmenopausal womenProgress in Cardiovascular Diseases, 1995
- Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal WomenAnnals of Internal Medicine, 1992
- Estrogen replacement therapy and the risk of venous thrombosisThe American Journal of Medicine, 1992
- Oral contraceptives and venous thromboembolism: findings in a large prospective study.BMJ, 1986
- Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic ProblemsObstetrics & Gynecology, 1979